Agenus Inc (AGEN)
7.91
+0.49
(+6.60%)
USD |
NASDAQ |
Apr 25, 11:10
Agenus Total Assets (Quarterly): 313.91M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 313.91M |
| September 30, 2023 | 335.47M |
| June 30, 2023 | 383.59M |
| March 31, 2023 | 412.85M |
| December 31, 2022 | 413.56M |
| September 30, 2022 | 429.02M |
| June 30, 2022 | 456.17M |
| March 31, 2022 | 441.30M |
| December 31, 2021 | 465.96M |
| September 30, 2021 | 437.64M |
| June 30, 2021 | 192.30M |
| March 31, 2021 | 234.92M |
| December 31, 2020 | 214.51M |
| September 30, 2020 | 204.48M |
| June 30, 2020 | 185.78M |
| March 31, 2020 | 180.06M |
| December 31, 2019 | 155.34M |
| September 30, 2019 | 174.81M |
| June 30, 2019 | 206.71M |
| March 31, 2019 | 245.93M |
| December 31, 2018 | 136.40M |
| September 30, 2018 | 130.48M |
| June 30, 2018 | 131.94M |
| March 31, 2018 | 130.82M |
| December 31, 2017 | 138.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 149.27M |
| June 30, 2017 | 176.49M |
| March 31, 2017 | 203.27M |
| December 31, 2016 | 156.99M |
| September 30, 2016 | 174.84M |
| June 30, 2016 | 196.45M |
| March 31, 2016 | 221.14M |
| December 31, 2015 | 242.23M |
| September 30, 2015 | 242.61M |
| June 30, 2015 | 180.11M |
| March 31, 2015 | 117.32M |
| December 31, 2014 | 74.53M |
| September 30, 2014 | 87.63M |
| June 30, 2014 | 100.19M |
| March 31, 2014 | 108.30M |
| December 31, 2013 | 34.84M |
| September 30, 2013 | 37.67M |
| June 30, 2013 | 21.37M |
| March 31, 2013 | 25.13M |
| December 31, 2012 | 29.09M |
| September 30, 2012 | 32.22M |
| June 30, 2012 | 33.27M |
| March 31, 2012 | 33.21M |
| December 31, 2011 | 19.81M |
| September 30, 2011 | 24.37M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
155.34M
Minimum
Dec 2019
465.96M
Maximum
Dec 2021
307.28M
Average
313.91M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Protalix BioTherapeutics Inc | 84.43M |
| InfuSystems Holdings Inc | 102.92M |
| PAVmed Inc | 33.12M |
| Allogene Therapeutics Inc | 642.84M |
| Pfizer Inc | 226.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 462.30M |
| Shareholders Equity (Quarterly) | -160.33M |
| Debt to Equity Ratio | -0.0805 |
| Current Ratio | 0.4393 |
| Net Debt Paydown Yield | 0.03% |